Skip to content
Filings

Thermo Fisher Scientific TMO Form 8-K filing Earnings

Filed
Jul 23, 2026, 6:04 AM EDT
Accession
0000097745-26-000138

Item 2.02 Results of Operations and Financial Condition.

On July 23, 2026, the Registrant announced its financial results for the fiscal quarter ended June 27, 2026. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Form 8-K and incorporated herein by reference.

The information contained in this report and exhibits hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

99.1 Press Release dated July 23, 2026

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)